APA (7th ed.) Citation

HF, Z., XM, Z., J, W., FF, C., CP, W., PY, D., . . . WP, L. (2021). Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients. Journal of translational medicine, 19(1), 372. https://doi.org/10.1186/s12967-021-02979-z

Chicago Style (17th ed.) Citation

HF, Zhao, et al. "Identification of Prognostic Values Defined by Copy Number Variation, MRNA and Protein Expression of LANCL2 and EGFR in Glioblastoma Patients." Journal of Translational Medicine 19, no. 1 (2021): 372. https://doi.org/10.1186/s12967-021-02979-z.

MLA (9th ed.) Citation

HF, Zhao, et al. "Identification of Prognostic Values Defined by Copy Number Variation, MRNA and Protein Expression of LANCL2 and EGFR in Glioblastoma Patients." Journal of Translational Medicine, vol. 19, no. 1, 2021, p. 372, https://doi.org/10.1186/s12967-021-02979-z.